BioSpace News Archive

SK Biopharmaceuticals and Ono Pharmaceutical announced that they have entered into an exclusive licensing agreement for Ono to develop and commercialize cenobamate in Japan. Cenobamate is a treatment for partial-onset seizures (POS) that received FDA approval in 2019.

CEFALY Technology today announced that the U.S. Food and Drug Administration (FDA) has cleared the CEFALY DUAL medical device as an over-the-counter (OTC) product

Epirium Bio, Inc., a clinical-stage biopharmaceutical company pursuing novel and clinically significant therapeutic approaches for neuromuscular, neurodegenerative and mitochondrial disorders, today announced the appointment of Alexander Casdin as chief financial officer (CFO) and member of the company’s executive team.

NeoGenomics continues to build its world-class pharma clinical research capabilities to include servicing Greater China-based clinical trials

Breg, Inc., a leading provider of orthopedic products and services designed to elevate patient care, today announced that its board of directors has appointed Stuart F. Simpson to executive chairman. Mr. Simpson has a distinguished record of spearheading inno

Alkame Holdings, Inc., a publicly traded holding company announced that in an effort to strengthen operations and innovation has named Craig Kaufman as Chairman of the company’s Board of Directors as well as hired several key additions to the executive leadership team.

Halberd Corporation reported that Arizona State University researchers, utilizing the intellectual property of Halberd Corporation, have successfully generated an anti-Spike protein monoclonal antibody against Covid-19.

WishBone Medical, Inc., a leader in pediatric orthopedic medical devices, today announced it has received U.S. Food and Drug Administration (FDA) 510(k) clearance on their Smart Correction ® External Fixation System, which comprises hexapod external fixator hardware and proprietary planning software. Used in facilities across Asia and Europe since 2009, the System boasts a proven record of higher accuracy [compared to Ilizarov fixators] and a de

Akoya Biosciences, Inc., The Spatial Biology Company®, today announced that the company received ISO 13485:2016 certification for the design, development, production, distribution and installation of medical devices and related services. Achieving this ISO certification s

Immersion Corporation (NASDAQ: IMMR), the leading developer and provider of technologies for haptics, today announced its support for the ANA Avatar XPRIZE – a competition challenging teams to develop a physical Avatar System that will transport an operator’s senses